Bo Ahrén

131 – 140 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
13
14
15
16
…
40
next »

2011
Mark Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice
Chan, Hui Min ; Jain, Ritesh ; Ahrén, Bo ^LU ; Pacini, Giovanni and D'Argenio, David Z. (2011) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 300(5). p.1126-1133
- Contribution to journal › Article
Mark The dynamic incretin adaptation and type 2 diabetes.
Ahrén, Bo ^LU (2011) In Journal of Clinical Endocrinology and Metabolism 96(3). p.620-622
- Contribution to journal › Article
Mark Editorial: Long in the shade, glucagon re-occupies centre court
Henquin, J. -C. ; Accili, D. ; Ahrén, Bo ^LU ; Boitard, C. ; Seino, S. and Cerasi, E. (2011) In Diabetes, Obesity and Metabolism 13(Suppl. 1).
- Contribution to journal › Debate/Note/Editorial
Mark Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice.
Sörhede Winzell, Maria ^LU ; Coghlan, Matthew ; Leighton, Brendan ; Frangioudakis, Georgia ; Smith, David M ; Storlien, Leonard H and Ahrén, Bo ^LU (2011) In European Journal of Pharmacology 663. p.80-86
- Contribution to journal › Article
Mark Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
Ahrén, Bo ^LU ; Schweizer, A. ; Dejager, S. ; Villhauer, E. B. ; Dunning, B. E. and Foley, J. E. (2011) In Diabetes, Obesity and Metabolism 13(9). p.775-783
- Contribution to journal › Scientific review
Mark Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.
Alam, M ; Van der Schueren, B J ; Ahrén, Bo ^LU ; Wang, G C ; Swerdlow, N J ; Arias, S ; Bose, M ; Gorroochurn, P ; Teixeira, J and McGinty, J , et al. (2011) In Diabetes, Obesity and Metabolism 13(4). p.378-381
- Contribution to journal › Article
Mark GLP-1 for type 2 diabetes
Ahrén, Bo ^LU (2011) In Experimental Cell Research 317(9). p.1239-1245
- Contribution to journal › Scientific review
Mark Positive correlation between tumor necrosis factor (TNF)-alpha and cardiorespiratory fitness after six-months of regular aerobic exercise in Peruvian Amerindian women
Lindgärde, Folke ^LU ; Gottsäter, Anders ^LU and Ahrén, Bo ^LU (2011) In Revista Médica de Chile 139(8). p.998-1005
- Contribution to journal › Article
Mark Incretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in Humans.
Lindgren, Ola ^LU ; Carr, Richard D ; Deacon, Carolyn F ; Holst, Jens J ; Pacini, Giovanni ; Mari, Andrea and Ahrén, Bo ^LU (2011) In The Journal of clinical endocrinology and metabolism 96. p.2519-2524
- Contribution to journal › Article
Mark Reply to the letter by P. Guillausseau Regarding "Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet Closed"
Ahrén, Bo ^LU (2011) In Current Diabetes Reports 11. p.463-463
- Contribution to journal › Article

« previous
1
…
13
14
15
16
…
40
next »